A trial for people with leukaemia or lymphoma who have already had IPI-145 or ofatumumab (IPI-145-12)

Please note

This trial is no longer recruiting patients. We hope to add results when they are available.

Overview

Cancer types:

Blood cancers, Cell type, Chronic leukaemia, Chronic lymphocytic leukaemia (CLL), Leukaemia, Low grade lymphoma, Lymphoma, Non-Hodgkin lymphoma (NHL)

Status:

Closed

Phase:

Phase 3

Details

This trial is for people with chronic lymphocytic leukaemia (CLL) or small lymphocytic lymphoma (SLL) who have already taken part in the IPI-145-07 trial.

If you have chronic lymphocytic leukaemia (CLL), white blood cells called lymphocytes are cancerous. If the cancerous lymphocytes are in your lymph nodes rather than in your blood, your doctors may call it small lymphocytic lymphoma (SLL). The treatments for CLL and SLL are the same.